Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reprise: gemtuzumab ozogamicin for older patients with acute myeloid leukemia.

Reprise: gemtuzumab ozogamicin for older patients with acute myeloid leukemia. J Clin Oncol. 2012 Nov 10; 30(32):3905-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.